Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.56 |
| ▸ | CTSK | P43235 | 4/20 | 0.52 |
| ▸ | CTSL | P07711 | 2/20 | 0.52 |
| ▸ | CTSS | P25774 | 2/20 | 0.52 |
| ▸ | CTSB | P07858 | 1/20 | 0.52 |
| ▸ | CAPN1 | P07384 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | CA7 | P43166 | 1/20 | 0.44 |
| ▸ | AAK1 | Q2M2I8 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27895527 | 0.85 | SMN1; SMN2 (0.58) | SMN1; SMN2CTSKCTSLCTSSCTSB | |
| SCHEMBL1701200 | 0.85 | SMN1; SMN2 (0.58) | SMN1; SMN2CTSKCTSLCTSSCTSB | |
| SCHEMBL15722121 | 0.84 | SMN1; SMN2 (0.67) | SMN1; SMN2CTSKCTSLCTSSCTSB | |
| SCHEMBL15722123 | 0.84 | SMN1; SMN2 (0.57) | SMN1; SMN2CTSKCTSLCTSSCTSB | |
| SCHEMBL701700 | 0.84 | SMN1; SMN2 (0.57) | SMN1; SMN2CTSKCTSLCTSSCTSB | |
| SCHEMBL4371611 | 0.84 | SMN1; SMN2 (0.57) | SMN1; SMN2CTSKCTSLCTSSCTSB | |
| SCHEMBL28968951 | 0.84 | SMN1; SMN2 (0.57) | SMN1; SMN2CTSKCTSLCTSSCTSB | |
| SCHEMBL28968948 | 0.84 | SMN1; SMN2 (0.57) | SMN1; SMN2CTSKCTSLCTSSCTSB | |
| SCHEMBL16130364 | 0.84 | CTSL (0.48) | SMN1; SMN2CTSKCTSLCTSSCTSB | |
| SCHEMBL21675512 | 0.83 | CTSK (0.61) | CTSKCTSLCTSSCTSBCAPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090275727-A1 | Peptide turn mimetics | MIMETICA PTY LIMITED (AU) | 2009-11-05 | — | — | US | disclosed |
| US-20090275727-A1 | Peptide turn mimetics | MIMETICA PTY LIMITED (AU) | 2009-11-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090275727-A1 | Peptide turn mimetics | IAPP, GLP1R, VIP | SMN1; SMN2 3304/4885CTSK 1231/4885CTSL 436/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.